Moreover, the PI3K-Akt signaling axis and sphingolipid metabolism, which are enriched in our high-risk group, have been implicated in both cardiotoxicity alleviation and immunotherapeutic response modulation in GBM (Wang L. et al., 2023; Wang et al., 2024). The gene discussed is AKT1; the disease is glioblastoma.